Joseph Catlett, MD, is an attending physician in the Section of Hematology/Medical Oncology and co-director of the Hematology Clinic at MedStar Washington Hospital Center. In this position, he is responsible for the education and training of medical students and fellows from the Hospital Center; Georgetown University; the National Heart, Lung and Blood Institute; Howard University; and the Uniformed Services University of the Health Sciences. In addition, he is an assistant professor of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD.
Dr. Catlett has been listed as a "Top Doctor" by Washingtonian magazine and Northern Virginia magazine and was named Educator of the Year in 2000 by the Hematology/Oncology fellows. At the Hospital Center, he is a member of the Clinical Improvement Committee and is co-chair of the Transfusion Committee.
Dr. Catlett has written chapters on hemolytic anemias, as well as articles in peer-reviewed journals, includingBlood, Leukemia and Lymphoma, Thrombosis Journal and Annals of Internal Medicine. He is a fellow of the American College of Physicians, and he is a member of the American Society of Hematology and the American Society of Clinical Oncology. He is board certified in Internal Medicine, Medical Oncology and Hematology. Dr. Catlett speaks frequently at local, regional and national professional meetings.
His medical degree is from West Virginia University School of Medicine, Morgantown, WV. He continued his training with a residency in Internal Medicine at West Virginia University Hospitals. He then completed a clinical fellowship in Hematology/Oncology at the Medical College of Virginia/Virginia Commonwealth University, Richmond, VA, where he also completed a research fellowship in Hematology/Oncology and Pharmacology/Toxicology in the Bone Marrow Transplantation Laboratory.
Dr. Catlett's research interests include
- Multiple myeloma
- Hemolytic anemia
- Benign hematology/coagulation
Primary Lymphoma of Bone
In this retrospective analysis of factors influencing survival in patients with primary lymphoma of bone treated at a single institution, Dr. Catlett and colleagues examined the records of 30 patients and evaluated them for overall survival as related to age, sex, stage, International Prognostic Index score, number of sites involved and type of treatment. This work was published in Leukemia and Lymphoma (2008;49:2125-2132).
- Research Areas